Defining the Prognostic Value for Galectin-3 in Cutaneous Melanoma

Authors: Vereecken, P.¹; Ghanem, G.²; Morandini, R.²; Suciu, S.³; Van Baren, N.⁴; Heenen, M.⁵

Source: The Journal of International Medical Research, Volume 35, Number 5, September 2007 , pp. 731-732(2)

Publisher: Field House Publishing

Buy & download fulltext article:

The full text is free.

View now:

PDF 59.3kb

Articles that cite this article?

Keywords: MELANOMA; GALECTIN-3; BIOMARKER

Document Type: Letter section

Affiliations: 1: Department of Dermatology, CHU Brugmann and Erasme Hospitals and the Jules Bordet Institute, Brussels, Belgium; Department of Medical Oncology, CHU Brugmann and Erasme Hospitals and the Jules Bordet Institute, Brussels, Belgium; Laboratory of Onc 2: Laboratory of Oncology and Experimental Surgery, Free University of Brussels, Brussels, Belgium 3: EORTC Data Center, Brussels, Belgium 4: Ludwig Institute for Cancer Research, Brussels Branch, Brussels, Belgium 5: Department of Dermatology, CHU Brugmann and Erasme Hospitals and the Jules Bordet Institute, Brussels, Belgium

Publication date: 2007-09-01

More about this publication?

The Journal of International Medical Research (JIMR) is a leading peer reviewed journal offering exceptional publication speed for medical, clinical and pre-clinical research. Reviews, case studies, preliminary communications, post-marketing surveillance, pharmacoeconomic and managed care studies are also welcome. Supplements publish symposium proceedings or collections of medical, pre-clinical or clinical data and enquiries from potential sponsors are welcome. JIMR is widely indexed and abstracted, including Medline, Current Contents and Excerpta Medica (EMBASE).
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
ingentaconnect is not responsible for the content or availability of external websites